These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 6753903

  • 1. Clinical and haemodynamic responses to captopril and hydralazine in chronic congestive heart failure: the importance of preload reduction.
    Fitzgerald DJ, O'Callaghan WG, O'Malley K, Horgan J, O'Brien E.
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):217S-222S. PubMed ID: 6753903
    [Abstract] [Full Text] [Related]

  • 2. Hemodynamic responses to combined therapy with captopril and hydralazine in patients with severe heart failure.
    Massie BM, Packer M, Hanlon JT, Combs DT.
    J Am Coll Cardiol; 1983 Aug; 2(2):338-44. PubMed ID: 6345633
    [Abstract] [Full Text] [Related]

  • 3. Mixed venous blood temperature response to exercise in heart failure patients treated with short-term vasodilators.
    Shellock FG, Rubin SA.
    Clin Physiol; 1985 Dec; 5(6):503-14. PubMed ID: 3912094
    [Abstract] [Full Text] [Related]

  • 4. Clinical and haemodynamic effects of low dose captopril in severe chronic heart failure.
    Sharpe DN, Coxon RJ.
    Br J Clin Pharmacol; 1982 Dec; 14 Suppl 2(Suppl 2):161S-167S. PubMed ID: 6753897
    [Abstract] [Full Text] [Related]

  • 5. Sustained haemodynamic and clinical effects of captopril in long-term treatment of severe chronic congestive heart failure.
    Ricci S, Zaniol P, Teglio V, Baraldi P, Mattioli G.
    Br J Clin Pharmacol; 1982 Dec; 14 Suppl 2(Suppl 2):209S-215S. PubMed ID: 6291564
    [Abstract] [Full Text] [Related]

  • 6. Converting-enzyme inhibitor therapy for chronic heart failure.
    Massie BM, Kramer BL, Topic N.
    Herz; 1983 Apr; 8(2):71-80. PubMed ID: 6343210
    [Abstract] [Full Text] [Related]

  • 7. Effects of captopril and a combination of hydralazine and isosorbide dinitrate on myocardial sympathetic tone in patients with severe congestive heart failure.
    Daly P, Rouleau JL, Cousineau D, Burgess JH, Chatterjee K.
    Br Heart J; 1986 Aug; 56(2):152-7. PubMed ID: 3524637
    [Abstract] [Full Text] [Related]

  • 8. Which vasodilator drug in patients with chronic heart failure? A randomised comparison of captopril and hydralazine.
    Schofield PM, Brooks NH, Lawrence GP, Testa HJ, Ward C.
    Br J Clin Pharmacol; 1991 Jan; 31(1):25-32. PubMed ID: 2015167
    [Abstract] [Full Text] [Related]

  • 9. Acute and long-term effects of captopril on exercise cardiac performance and exercise capacity in congestive heart failure.
    Kramer B, Topic N, Massie B.
    Br J Clin Pharmacol; 1982 Jan; 14 Suppl 2(Suppl 2):143S-151S. PubMed ID: 6753895
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term response.
    Chatterjee K, Parmley WW, Cohn JN, Levine TB, Awan NA, Mason DT, Faxon DP, Creager M, Gavras HP, Fouad FM.
    Am Heart J; 1985 Aug; 110(2):439-47. PubMed ID: 3895877
    [Abstract] [Full Text] [Related]

  • 13. Captopril in congestive heart failure resistant to other vasodilators.
    Fouad FM, El-Tobgi S, Tarazi RC, Bravo EL, Hart NJ, Shirey EK, Lim J.
    Eur Heart J; 1984 Jan; 5(1):47-54. PubMed ID: 6368232
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Acute and long-term effects of captopril on exercise cardiac performance and exercise capacity in congestive heart failure.
    Topic N, Kramer B, Massie B.
    Am Heart J; 1982 Nov; 104(5 Pt 2):1172-9. PubMed ID: 6291362
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure.
    Steimle AE, Stevenson LW, Chelimsky-Fallick C, Fonarow GC, Hamilton MA, Moriguchi JD, Kartashov A, Tillisch JH.
    Circulation; 1997 Aug 19; 96(4):1165-72. PubMed ID: 9286945
    [Abstract] [Full Text] [Related]

  • 20. Captopril in congestive heart failure: improved left ventricular function with decreased metabolic cost.
    Chatterjee K, Rouleau JL, Parmley WW.
    Am Heart J; 1982 Nov 19; 104(5 Pt 2):1137-46. PubMed ID: 6291359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.